학술논문
Plasma Progastrin-releasing peptide (ProGRP) level well predicts the degree and duration of PSA response in patients with metastatic castration-resistant prostate cancer underwent enzalutamide
Document Type
article
Author
Source
European Urology Open Science, Vol 19, Iss , Pp e895- (2020)
Subject
Language
English
ISSN
2666-1683